Fred Alger Management’s Assembly Biosciences ASMB Stock Holding History

Fred Alger Management’s Portfolio ASMB Stock Details ASMB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-833	Closed	-$392K	–	539
2018 Q2	$392K	Buy	833 +250	+43%	+$132K	﹤0.01%	364
2018 Q1	$344K	Buy	+583	New	+$361K	﹤0.01%	386

Other funds holding ASMB

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

ACP

Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Fred Alger Management's ASMB Position: Q3 2018 in Review

Fred Alger Management sold out of Assembly Biosciences (ASMB) in Q3 2018, closing a stake of 833 shares — an estimated $392K sold.

Fred Alger Management first reported a position in ASMB in Q1 2018 and held it in 2 quarters. The position peaked at $392K in Q2 2018. 113 funds tracked by Wall St. Rank hold ASMB as of Q3 2018.

Fred Alger Management reported no remaining Assembly Biosciences position as of Q3 2018 after selling out during the quarter.
Fred Alger Management sold 833 Assembly Biosciences shares in Q3 2018, an estimated $392K.
Fred Alger Management first reported a position in Assembly Biosciences in Q1 2018 and held it in 2 quarters.
Fred Alger Management's Assembly Biosciences position peaked at $392K in Q2 2018.
113 funds tracked by Wall St. Rank held Assembly Biosciences as of Q3 2018.

Based on Fred Alger Management's 13F filing for Q3 2018, filed 14 Nov 2018.